Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
124542882	12454288	2	F	20160309	20160803	20160610	20160805	EXP		PHEH2016US014258	NOVARTIS		71.88	YR		M	Y	51.25000	KG	20160805		CN	US	US

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	LOT NUM	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
124542882	12454288	1	PS	GLEEVEC	IMATINIB MESYLATE	1	Oral	400 MG, BID	F0029	21588	400	MG	TABLET	BID
124542882	12454288	2	SS	GLEEVEC	IMATINIB MESYLATE	1	Oral	800 MG, UNK		21588	800	MG	TABLET
124542882	12454288	3	SS	GLEEVEC	IMATINIB MESYLATE	1	Oral	400 MG, QD	F0034	21588	400	MG	TABLET	QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
124542882	12454288	1	Gastrointestinal carcinoma

Outcome of event

Event ID	CASEID	OUTC COD
124542882	12454288	DE
124542882	12454288	OT

Reactions reported

Event ID	CASEID	PT
124542882	12454288	Death
124542882	12454288	Dysgeusia
124542882	12454288	Dysphagia
124542882	12454288	Hepatic lesion
124542882	12454288	Retching
124542882	12454288	Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
124542882	12454288	1	20150220		0
124542882	12454288	3	20160627		0